ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 425 out of 6969

$375K Total Retail Price of All Prescriptions

Rank: 1071 out of 6969

372 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,337 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 798 734 1 1
LISINOPRIL 572 496 2 2
AMLODIPINE BESYLATE 493 458 3 4
LEVOTHYROXINE SODIUM 380 356 4 5
ATENOLOL 327 320 5 9
FUROSEMIDE 312 299 6 10
OMEPRAZOLE 279 246 7 6
HYDROCODONE-ACETAMINOPHEN 262 244 S3 8 3
HYDROCHLOROTHIAZIDE 214 209 9 8
METFORMIN HCL 214 147 9 7
LOSARTAN POTASSIUM 208 191 11 12
POTASSIUM CHLORIDE 193 186 12 30
METOPROLOL TARTRATE 176 165 13 13
METOPROLOL SUCCINATE 152 140 14 22
LOVASTATIN 151 147 15 15
CARVEDILOL 135 129 16 25
WARFARIN SODIUM 130 128 17 20
ALENDRONATE SODIUM 126 123 18 14
ZOLPIDEM TARTRATE 116 115 19 16
ATORVASTATIN CALCIUM 115 93 20 11
GLIPIZIDE 110 99 21 21
DIGOXIN 105 93 22 71
PRAVASTATIN SODIUM 103 80 23 19
BENAZEPRIL HCL 102 91 24 18
PANTOPRAZOLE SODIUM 99 76 25 31
DIOVAN 98 98 26 26
ALLOPURINOL 93 82 27 35
DOXAZOSIN MESYLATE 89 76 28 74
CLOPIDOGREL 87 80 29 48
FLUTICASONE PROPIONATE 81 75 30 24
FELODIPINE ER 77 67 31 116
TAMSULOSIN HCL 75 74 32 23
TERAZOSIN HCL 74 74 33 49
RANITIDINE HCL 72 71 34 46
GLIPIZIDE ER 70 59 35 199
OXYBUTYNIN CHLORIDE 68 65 36 126
DONEPEZIL HCL 67 67 37 32
CHLORTHALIDONE 64 62 38 152
PREDNISONE 62 61 39 70
GABAPENTIN 62 61 39 17
FLUOXETINE HCL 57 57 41 43
PROAIR HFA 57 55 41 33
MIRTAZAPINE 52 52 43 76
FINASTERIDE 50 49 44 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.